Ref.: BL-RE-106298Manufacturer ref.: EH294RBX5 5 x 96 tests
€2,950.00 excl. VAT
Human LAMP1/CD107a quantitates human LAMP1/CD107a in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LAMP1/CD107a.
Accession number
Glycoprotéine membranaire lysosomale de 120 kDa ; AI196048 ; membre de la famille similaire à l’antigène CD107 A ; CD107a ; I79_011073 ; Lamp I ; Lamp1 ; LAMP-1 ; LAMPA ; LGP120 ; LGP-120 ; Lgpa ; LGP-A ; protéine membranaire associée aux lysosomes 1 ; protéine membranaire associée aux lysosomes 1 (120 kDa) ; glycoprotéine membranaire lysosomale 1 ; glycoprotéine membranaire lysosomale A ; protéine membranaire associée aux lysosomes 1 ; glycoprotéine membranaire associée aux lysosomes 1 ; PRÉCURSEUR DE GLYCOPROTÉINE MEMBRANAIRE ASSOCIÉE AUX LYSOSOMES 1 (LAMP-1) (LGP-A) (LGP-120) (CD107A) (P2B) ; protéine membranaire associée aux lysosomes 1 ; P2B
Dose range
1.229 to 300 ng/ml
Sensitivity of the dosage
1 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human LAMP1/CD107a quantitates human LAMP1/CD107a in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LAMP1/CD107a.
Human LAMP1/CD107a quantitates human LAMP1/CD107a in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LAMP1/CD107a.
LAMP1 (CD107a, membrane protein associated with lysosome-1) and LAMP-2 are a major component of the lysosole membrane, and 1-2% of the total CD107a is also present on the plasma membrane. LAMP1 is a highly glycosylated membrane protein that contains a putative signal peptide, 18 sites for N-linked glycosylation, a single transmembrane segment and a short cytosolic tail (11 amino acids). LAMP proteins are involved in lysosome biogenesis and are necessary for the fusion of lysosomes with phagosomes. LAMP1 is a Type 1 integral membrane protein that is transported from the trans-Golgi network to endosomes and then lysosomes. During cell activation, the transfer of LAMP1 to the plasma membrane depends on a tyrosine-based carboxylic end (YXXI) pattern. Disturbing the spacing between the tyrosine-based pattern and the membrane suppresses the location of LAMP1 lysosome and this mutant protein then moves between the plasma membrane and the endosome. Cell surface LAMP1 and LAMP2 have been shown to promote the adhesion of human peripheral blood mononucleal (PBMC) cells to vascular endothelium. Therefore, they are probably involved in PBMC adhesion to the site of inflammation. An increase in LAMP1 immunoreactivity is observed in neurons and glial cells surrounding senile plaques in Alzheimer's disease (MA) and is located in spinal cord epithelial cells, single macrophages and lymphocytes in acute thymic involution. LAMP1 is a good marker for mast cell activation.
Sensitivity
Sensitivity of dosage: 1 ng/ml.
Measurement range
Dose range: 1.229 to 300 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: LAMP1 (CD107a).
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; Serum, 50 µl; Plasma, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17185059
Specifications
Accession number
120 kDa lymphosomal membrane glycoprotein; AI196048; member of the family similar to CD107 A antigen; CD107a; I79_011073; Lamp I; Lamp1; LAMP-1; LAMPA; LGP120; LGP-120; Lgpa; LGP-A; membrane protein associated with lysosomes 1; membrane protein associated with lysosomes 1 (